MEDINDIA

Search Medindia

INCOVACC, Made-In-India Intranasal COVID-19 Vaccine to be Launched on R-Day

by Colleen Fleiss on Jan 22 2023 11:35 PM
Listen to this article
0:00/0:00

On Republic day, Bharat Biotech has planned to launch its intranasal COVID-19 vaccine, revealed sources.

INCOVACC, Made-In-India Intranasal COVID-19 Vaccine to be Launched on R-Day
India’s first intranasal COVID-19 vaccine iNCOVACC manufactured by Bharat Biotech, will launch on January 26, announced the company’s CMD Krishna Ella.
The vaccine manufacturer had already received approval from the Central Drugs Standard Control Organisation (CDSCO) earlier this month for the nasal vaccine, the first of its kind in India.

India’s First Intra-Nasal COVID-19 Vaccine

"Our nasal vaccine will be officially launched on Republic Day on January 26," said Ella while participating in a session during the 8th edition of the India International Science Festival (IISF) that began at the Maulana Azad National Institute of Technology (MANIT), here on Saturday.

TOP INSIGHT

Did You Know

Intranasal immunization of ChAd-SARS-CoV-2-S can create an immune response in the nose, which is the point of entry for the virus, thereby protecting against disease, infection, and transmission.

The session was titled 'Face-to-Face with New Frontiers in Science'.

The company had earlier announced that it would price the intranasal vaccine at Rs.325 per shot for procurement by the government, and Rs.800 per shot for private vaccination centers.

As per the vaccine manufacturer, the nasal route has excellent potential for vaccination due to the organized immune system of the nasal mucosa.

The nasal vaccine can be taken six months after the second dose.

Source-IANS



⬆️